View of Doxorubicin-Melphalan with and Without Cisplatin in Advanced Ovarian Cancer: Ten-year survival results from a prospective randomized study by the Swedish Cooperative Ovarian Cancer Study Group

Return to Article Details Doxorubicin-Melphalan with and Without Cisplatin in Advanced Ovarian Cancer: Ten-year survival results from a prospective randomized study by the Swedish Cooperative Ovarian Cancer Study Group Download Download PDF